Actively Recruiting

Phase Not Applicable
Age: 0 - 18Years
All Genders
NCT06818916

Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma

Led by Beijing Children's Hospital · Updated on 2025-12-03

30

Participants Needed

1

Research Sites

160 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if hetrombopag promotes platelet engraftment in neuroblastoma children undergoing autologous hematopoietic stem cell transplantation. The main question it aims to answer is: · Does drug hetrombopag promote platelet engraftment? Participants will take hetrombopag every day for 6 weeks or until platelet \> 100\*10\^9/L.

CONDITIONS

Official Title

Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma

Who Can Participate

Age: 0 - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Younger than 18 years old
  • Diagnosed with neuroblastoma
  • ECOG performance status of 2 or less
  • Receiving first autologous hematopoietic stem cell transplantation
  • Participant or legal guardian agrees to participate and signs informed consent
Not Eligible

You will not qualify if you...

  • Liver enzymes ALT or AST greater than 3 times the normal upper limit, or total bilirubin greater than 1.5 times the normal upper limit
  • History of congestive heart failure, arrhythmia, or peripheral blood clots requiring medication in the past year
  • History of heart attack or stroke within the past 3 months
  • Having thromboembolic diseases
  • Any other conditions deemed unsuitable by the researchers

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Stem Cell Transplantation, Beijing Children's Hospital, Capital Medical University

Beijing, China

Actively Recruiting

Loading map...

Research Team

D

Dr. Yang

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here